Glasdegib Completed Phase 1 Trials for Malignancies, Hematologic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00953758A Study Of PF-04449913 In Select Hematologic Malignancies